Sun Pharma fixes production problems at NY plant; Doctors escape sanctions in U.S. pharma settlements;

@FiercePharma: Looking for generics in India? Strides Arcolab is open to selling its copycat business to fund specialty ops - WSJ. News | Follow @FiercePharma

> Sun Pharmaceutical has resolved manufacturing problems at its Cranbury, NY, plant to the FDA's satisfaction, but its Caraco subsidiary is still working to fix its regulatory woes. More

> When drugmakers have settled marketing and kickback probes with the U.S. Justice Department, doctors named as participants were not punished, ProPublica reports. Report

> In a move to quell the growth of resistant infections in humans, infectious disease experts are promoting a plan that would require U.S. farmers to get prescriptions for livestock antibiotics. Item

> Up-and-coming Indian drugmakers are aggressively competing on price, drawing sales away from bigger, more established firms, the Business Standard finds. Story

> Over-prescribing is "chronic" in Europe, a study has found, with 36% of drugs prescribed to patients averaging 82 years of age deemed "unnecessary" and 30% "inappropriate." More

> The U.S. government isn't collecting enough data on antibiotic use in livestock and on resistant bacteria in animals and meat to properly study the potential links among them, the GAO said. Report

> As more Americans take prescription drugs, more kids suffer accidental poisonings at home, according to a new study. Story

> California schools sent middle- and high-school students home if they had not received the whooping cough vaccine required under a new law. Article

> Logistics company Agility's pharma distribution capabilities have been certified at its Pharmaceutical Competence Center in Switzerland. Report

Biotech News

@FierceBiotech: @John_LaMattina's rebuttal to the Forbes piece on this topic is worth a read Article --RM | Follow @FierceBiotech

@JohnCFierce: Lots of ICAAC news over the weekend, including positive data from NexBio on second-line flu therapy. Item | Follow @JohnCFierce

@RyanMFierce: More life sciences gaming news this AM: Gamers crack structure of AIDS enzyme Story | Follow @RyanMFierce

@MaureenFierce: RT @spettypi: Non-contagious disease will cost the world $47 trillion over the next 20 years--about 75% of global GDP in 2010. | Follow @MaureenFierce

> Sangamo's HIV gene treatment shows breakthrough promise in tiny trial. Item

> Kythera lands $37M D round for PhIII fat-zapping study. Report

Biotech IT News

> Video gamers uncover AIDS drug targets. Story

> Computer-based therapy relieves fears. Report

> BioData scoops up assets of competitor LabLife. Article

> U.K. mulls drug-reaction reports on Twitter, Facebook. Story

> Supercomputers combat bad drug events for Boston hospital. Piece

> Biomatters sets up U.S. beachheads. More

Medical Devices News

@FierceMedDev: An app a day keeps the doctor away? Report | Follow @FierceMedDev

> Covidien to establish R&D center in Shanghai. Article

> Wright, feds agree to defer prosecution. Report

> Cellnovo gets CE Mark for first mobile diabetes system. News

> GE looks to Russia with 2 new JVs. More

> Celerus raises $10M in Series C. Item

> ConvaTec reportedly out of the running for KCI. News

And Finally... Billions budgeted for new health spending spawn corruption, scandal and violence in Uttar Pradesh, India--and little new healthcare. Piece

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.